Biomedical Science Research Center “Alexander Fleming” (BSRC FLEMING)

The Biomedical Science Research Center “Alexander Fleming” (BSRC FLEMING) was established through the efforts of Amalia Koutsouri-Fleming, a microbiologist and wife of Alexander Fleming, the Nobel Laureate 1945 in Medicine. She had the vision for a Greek Center of Scientific and Technological Excellence, based on meritocracy, excellence and innovation purposed to attract and develop young Greek researchers.
BSRC FLEMING started its operation in 1999 and is nowadays a top-ranked non-profit research organization of 23 group leaders and 130 researchers, with a mission to perform cutting edge basic and translational research in biomedical sciences, provide state-of the-art training and mentorship to scientists and students of all levels, offer high end scientific and technological services, and engage in technology transfer and innovation. The center is located in an area of 128.000 sq.m. in Vari, a region on the Athenian Riviera. The Fleming Museum of Contemporary Science is also housed on the premises of the research center.

Read More
Its main research directions include Immunity & Inflammation, Neuroscience, Cancer Biology, RNA Biology & Epigenetics, Bioinformatics & Computational Biology. Additionally, BSRC FLEMING has recently established its frontier research in Biomolecular Engineering & Synthetic Biology with a European Research Area chair (ERA Chair), Dr. Georgios Skretas. These research directions reflect the work of its group leaders and serve as links between the two FLEMING Institutes: Institute for Bioinnovation (IBI) and Institute for Fundamental Biomedical Research (IFBR). The focus of IFBR is on unravelling the molecular and cellular basis of disease via novel animal models of human pathologies, while IBI’s vision is to advance fundamental research achievements towards innovative translational biotechnologies and drug development.
BSRC FLEMING’s strength and international recognition arises from pioneering research towards understanding the molecular and cellular basis of human diseases, and development and validation of relevant animal models of chronic inflammatory diseases, neurodegenerative disorders, metabolic diseases, cancer and autoimmune syndromes, among others, and the development of new approaches for their diagnosis and treatment, using transdisciplinary approaches and state-of the art facilities and technologies. It is of note that several of its researchers have been included in the list of outstanding research leaders in Europe awarded ERC grants.
The center also coordinates two major Research Infrastructures (RIs) for modeling human diseases and bioinformatics/biocomputing resources, while it participates in personalized medicine, precision oncology and bioimaging RIs.